2002 sales: up 83.5%

07/17/2014
In EUR millions 2002 2001 Change as a %
Q1 7.29 3.89 +87.2%
Q2 8.03 4.50 +78.4%
Q3 7.29 3.85 +89.6%
Q4 6.98 3.88 +79,8%
Full year 29.59 16.12 +83.5%

2002 sales for Naturex stood at EUR 29.6 million, up 83.5% from the previous period and
 perfectly in line with the Group’s start-of-year forecasts.
 Organic growth remained buoyant throughout the year, amounting to 30.8% for the year
 ending December 31, 2002. The dollar effect excluded, the company’s BRUCIA Plant
 Extracts activity enjoyed growth of 7% over the year.
 Overall, and pro-forma, growth stood at 20.8%.
 Production for the Food and Flavor industries accounted for 52% of activity in 2002, with
 production for the Nutraceutical industries and extraction activities accounting for 42% and
 6% respectively.
 53% of sales were realized in the United States and Canada, with sales in France and the
 European Union accounting for 9% and 30% of total sales generated.

Merger between S2P and Naturex SA approved

The merger between the holding company S2P and Naturex SA was approved by the Special
 Shareholders’ Meeting which was held on December 16 of last year. Once the merger is
 complete, the number of shares will remain unchanged at 2,164,518, with Jacques Dikansky
 holding 22.8% of Naturex SA’s capital and 36% of the voting rights. The company’s
 remaining capital is held by the market, including an 8.1% stake held by Natexis
 Investissement and a 5.5% stake held by Moussahama, both of which are long-standing
 shareholders in Naturex.

ISIN : FR0000054694-NRX
 Reuters : NATU.LN
 Bloomberg : NTRX

Contacts

NATUREX
 Thierry LAMBERT
 on +33 (0)4 90 23 96 89
ACTUS
 Marion Brossard
 on +33 (0)1 53 67 36 57
 
of 228
BACK